Management of Solitary Left-Sided Pleural Effusion in Heart Failure

Initial Clinical Assessment

Unilateral left-sided pleural effusions occur in up to 41% of heart failure cases and should prompt diagnostic thoracentesis to exclude non-cardiac causes, according to the European Respiratory Journal 1, 2
Evaluate for features suggesting alternative diagnoses that mandate thoracentesis, such as weight loss, chest pain, or fevers, as recommended by the European Respiratory Journal 3
Pleuritic chest pain or leukocytosis may indicate non-cardiac etiology, as suggested by the European Respiratory Journal and Praxis Medical Insights 3, 4

Perform ultrasound-guided thoracentesis if unilateral left-sided effusion is present, even with known heart failure, as recommended by Praxis Medical Insights and the European Respiratory Journal 4, 5
Any clinical features suggesting non-cardiac etiology, such as those recommended by the European Respiratory Journal, warrant thoracentesis 3
Effusion persistence after 5 days of optimized diuretic therapy requires repeat thoracentesis, according to Praxis Medical Insights 4

Optimize heart failure therapy as first-line treatment, including furosemide and combination therapy with thiazide-type diuretic or spironolactone for refractory cases, as recommended by Praxis Medical Insights 4
IV vasodilators may be used for symptomatic relief if systolic blood pressure is >90 mmHg, according to Praxis Medical Insights 4

Typical heart failure effusions should improve within 5 days of optimized medical therapy, as suggested by Praxis Medical Insights 4, 5
Persistent or worsening effusion despite adequate diuresis warrants repeat thoracentesis, according to Praxis Medical Insights 4

For symptomatic effusions despite maximal tolerated diuretic therapy, consider indwelling pleural catheter (IPC) only if frequent thoracenteses are required, as recommended by the European Respiratory Journal and Praxis Medical Insights 4, 6
Talc pleurodesis achieves higher pleurodesis rates but is associated with longer hospital stay, higher readmission rates, and greater morbidity compared to IPC alone, according to the European Respiratory Journal and Praxis Medical Insights 1, 4

Presence of pleural effusion in heart failure indicates greater cardiac comorbidity and cardiovascular mortality risk, as suggested by the European Respiratory Journal 6
In end-stage renal failure patients with heart failure, 6-month and 1-year mortality rates are 31% and 46%, respectively, according to the European Respiratory Journal 6